Navigation Links
STAAR Surgical To Present At Upcoming Investor Conferences
Date:5/21/2013

MONROVIA, Calif., May 21, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in three upcoming investor conferences to review the Company's recent financial results and business developments with investors and interested parties.

STAAR Surgical will present at the 38th Annual Deutsche Bank 2013 Healthcare Conference in Boston at the Westin Waterfront Hotel on Wednesday, May 29, 2013 at 10:40 a.m. ET.  Barry G. Caldwell , President and CEO and Hans Blickensdoerfer, President, Europe, Middle East, Africa, will be presenting at the conference.

The Benchmark Company One-on-One Investor Conference will be held on Thursday, May 30, 2013 at the Pfister Hotel in Milwaukee, Wisconsin.  Barry Caldwell and Hans Blickensdoerfer will meet with interested investors in a series of one-on-one meetings.

The Company will also present at the Jefferies 2013 Global Healthcare Conference at the Grand Hyatt Hotel in New York on Thursday, June 6, 2013 at 2:00 p.m. ET.  Barry Caldwell and Sam Gesten , General Counsel, will be presenting at the conference.

STAAR will offer a live video webcast of its presentations at Deutsche Bank and Jefferies on the Company's website, www.staar.com, under Investor Information. An archived replay of these presentations will be available for 90 days following the event date, also at www.staar.com.  The Benchmark conference does not provide for companies to webcast the event.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.CONTACT:

Investors

MediaEVC Group

EVC GroupDouglas Sherk, 415-652-9100

Amy Phillips, 412-327-9499 Leigh Salvo, 415-568-9348
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
2. STAAR Surgical Provides Preliminary First Quarter Revenue Results
3. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
4. STAAR Surgical Reports Third Quarter 2012 Financial Results
5. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
6. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
7. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
8. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
9. STAAR Surgical Reports Second Quarter 2012 Financial Results
10. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
11. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 2017 , ... As President Trump challenges the status quo ... administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, for ... make it through Congress. His discussion will focus on the current state of ...
(Date:4/25/2017)... NV (PRWEB) , ... April 25, 2017 , ... ... now choose a modern procedure that achieves results in a fraction of the ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from medical ... heartened by the industry’s current surge. But another thing that unifies them is a ... last they can simply, safely and effectively end their aroma anguish thanks to a ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South Florida ... report in the May issue of Consumer Reports focused on heart health. , ... achieved during and after coronary bypass and aortic valve replacement procedures. , Consumer ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare Solutions ... (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , BYOD ... devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. “BYOD ...
Breaking Medicine News(10 mins):